Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human

Vaccine ◽  
2009 ◽  
Vol 27 (21) ◽  
pp. 2899-2904 ◽  
Author(s):  
Galina N. Leonova ◽  
Elena V. Pavlenko
Vaccine ◽  
2007 ◽  
Vol 25 (5) ◽  
pp. 895-901 ◽  
Author(s):  
Galina N. Leonova ◽  
Vladimir A. Ternovoi ◽  
Elena V. Pavlenko ◽  
Olga S. Maistrovskaya ◽  
Elena V. Protopopova ◽  
...  

2016 ◽  
Vol 213 ◽  
pp. 6-10 ◽  
Author(s):  
Xiaowei Zhang ◽  
Zhenhua Zheng ◽  
Bo Shu ◽  
Panyong Mao ◽  
Bingke Bai ◽  
...  

Viruses ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1494
Author(s):  
Ivan K. Baykov ◽  
Pavel Y. Desyukevich ◽  
Ekaterina E. Mikhaylova ◽  
Olga M. Kurchenko ◽  
Nina V. Tikunova

Tick-borne encephalitis virus (TBEV) causes 5−7 thousand cases of human meningitis and encephalitis annually. The neutralizing and protective antibody ch14D5 is a potential therapeutic agent. This antibody exhibits a high affinity for binding with the D3 domain of the glycoprotein E of the Far Eastern subtype of the virus, but a lower affinity for the D3 domains of the Siberian and European subtypes. In this study, a 2.2-fold increase in the affinity of single-chain antibody sc14D5 to D3 proteins of the Siberian and European subtypes of the virus was achieved using rational design and computational modeling. This improvement can be further enhanced in the case of the bivalent binding of the full-length chimeric antibody containing the identified mutation.


2011 ◽  
Vol 11 (6) ◽  
pp. 659-664 ◽  
Author(s):  
Emina Durmiši ◽  
Nataša Knap ◽  
Ana Saksida ◽  
Tomi Trilar ◽  
Darja Duh ◽  
...  

1969 ◽  
Vol 67 (4) ◽  
pp. 731-738 ◽  
Author(s):  
V. Mayer ◽  
D. Blaškovič ◽  
E. Ernek ◽  
H. Libíková

SUMMARYThe vaccination of sheep with one dose of the monkey-and mouse-attenuated tick-borne encephalitis virus (the Hy-HK 28 ‘2’ clone) causes seroconversion from negative into positive in 85% of animals. In sheep with pre-existing virus-neutralizing antibodies and increas of their titres was observed in 81%. The antibodies persisted for at least 12 months after the vaccination and during the summer period of grazing the number of serologically positive animals even increased.The vaccinated animals, in contrast to the non-immune control sheep, developed no viraemia after challenge with the virulent louping-ill virus, performed 11 months after immunization.


2015 ◽  
Vol 6 (1) ◽  
pp. 38-46 ◽  
Author(s):  
Petra Formanová ◽  
Jiří Černý ◽  
Barbora Černá Bolfíková ◽  
James J. Valdés ◽  
Irina Kozlova ◽  
...  

2000 ◽  
Vol 44 (6) ◽  
pp. 533-536 ◽  
Author(s):  
Kimiyo Komoro ◽  
Daisuke Hayasaka ◽  
Tetsuya Mizutani ◽  
Hiroaki Kariwa ◽  
Ikuo Takashima

Sign in / Sign up

Export Citation Format

Share Document